Diominic DA Tablet
By Diominic DA
Rx
10 Tablet in a Strip

Composition
Paracetamol(NA) + Phenylpropanolamine(NA) + Chlorpheniramine Maleate(NA)

Manufacturer - Unison Pharmaceuticals Pvt Ltd
Unison Pharmaceuticals Pvt. Ltd., UNISON HOUSE Near Prernatirth Derasar, Near Ratnadeep-II, Satellite, Jodhpur, Ahmedabad-380 015, GUJARAT, INDIA.

Expires on or after
February, 2027

liver
When using Diominic DA Tablet, caution is advised for patients with liver disease. It may be necessary to adjust the dosage of Diominic DA Tablet in such cases. It is important to consult your doctor before taking this medication. However, it is not recommended to use Diominic DA Tablet in patients with severe liver disease or active liver disease. Remember to always seek guidance from your healthcare provider when considering the use of Diominic DA Tablet.

kidney
Diominic DA Tablet is considered safe for patients with kidney disease. There is limited data indicating no need for dose adjustment. However, it may cause excessive sleepiness in those with end-stage kidney disease.Consult your doctor before using Diominic DA Tablet.

alcohol
It is not safe to drink alcohol while taking Diominic DA Tablet. Avoid alcohol when using this medication. Consult your doctor when cosuming alcohol with Diominic DA Tablet.

driving
When taking Diominic DA Tablet, be cautious while driving as it may reduce alertness, cause drowsiness, and affect vision. Avoid driving if you experience these symptoms.

pregnancy
Caution is advised when using Diominic DA Tablet during pregnancy. Limited human studies and animal research suggest potential harm to the baby. Consult your doctor for a thorough evaluation of the risks and benefits before using this medication during pregnancy.

breastfeeding
It is better to consult your doctor before using Diominic DA Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹18.3
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024